Shiqi Li - 920th Hosp OfJoint Logist Support Force Peoples C

基本信息

浏览量：0

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 11 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Modified Lentiviral Globin Gene Therapy for Pediatric Β0/β0 Transfusion-Dependent Β-Thalassemia: A Single-Center, Single-Arm Pilot Trial

Shiqi Li,Sikai Ling,Dawei Wang,Xiaoyuan Wang, Fangyuan Hao, Liufan Yin,Zhongtao Yuan,Lin Liu,Lin Zhang,Yu Li,Yingnian Chen,Le Luo, Ying Dai, Lihua Zhang,Lvzhe Chen, Dongjie Deng,Wei Tang,Sujiang Zhang,Sanbin Wang,Yujia Cai

Cell stem cell (2024)

引用0浏览0WOS引用

Stable Engraftment, As Well As Graft Versus Host Disease‐free and Relapse‐free Survival Brought by the Combination of CD7 Targeted Universal Chimeric Antigen Receptor‐t, and Donor Hemopoietic Stem Cells: Indication of a Case Report

Shiqi Li,Zhongtao Yuan,Lin Liu,Yu Li,Le Luo,Lihui Peng, Mengli Xu,Ping Yin,Yingnian Chen,Xiaoping Li, Qingying Zang,Xi Zhang,Sanbin Wang

EJHAEMno. 3 (2024): 584-588

引用0浏览0WOS引用

Examining Safety and Durable Disease Remission in R/R B-ALL after Autologous CD19-directed CAR T Cells Produced by Novel PRIMCAR Manufacture Platform

Zhi Yang,Shiqi Li,Yu Li,Lin Liu,Zhongtao Yuan,Yingzi Zhang,Le Luo, Lihua Zhang,Yingnian Chen,Qianzhen Zhang,Junjie Shen,Yunyan Li,Linling Wang,Meiling Wang,Wei Zhu,Xiao He,Youcheng Wang,Yancheng Dong,Sanbin Wang, Cheng Qian

JOURNAL OF CLINICAL ONCOLOGYno. 16 (2023)

引用0浏览0引用

CD7 targeted “off-the-shelf” CAR-T demonstrates robust in vivo expansion and high efficacy in the treatment of patients with relapsed and refractory T cell malignancies

Shiqi Li,Xinxin Wang,Lin Liu,Jia Liu,Jun Rao,Zhongtao Yuan,Li Gao,Yu Li,Le Luo, Gui Li,Zhimin Li, Sheng Li,Jiaping He,Lihua Zhang,Lvzhe Chen, Wenhui Huang,Ping Yin, Chunmin Li,Xiaoping Li,Youcheng Wang,Yancheng Dong,Dingsong Zhang, Qingying Zang,Yingnian Chen,Lianjun Shen, Wenling Li,Wei Cao,Xi Zhang,Sanbin Wang

Leukemiano. 11 (2023): 2176-2186

引用0浏览0WOSNATURE引用

Safety and Efficacy of GPRC5D CAR T Cell Therapy in Relapsed/Refractory Multiple Myeloma Patients

Shiqi Li,Zhongtao Yuan,Lin Liu,Yu Li,Le Luo,Yingnian Chen,Lihua Zhang,Guangchao Li,Min Luo, Kaikai Zeng,Donghui Ma, Sr. Wang Sanbin

Bloodno. Supplement 1 (2023): 3472-3472

引用0浏览0引用

Safety and Efficacy Profile of a Very Low Dose of MC-1-50 for Treatment of R/r NHL

Shiqi Li,Zhi Yang,Lin Liu,Zhongtao Yuan,Yingzi Zhang,Le Luo,Lihua Zhang,Yingnian Chen,Qianzhen Zhang,Junjie Shen,Yunyan Li,Linling Wang,Meiling Wang,Wei Zhu,Yufeng Huang,Youcheng Wang,Yancheng Dong,Sanbin Wang, Cheng Qian

JOURNAL OF CLINICAL ONCOLOGYno. 16 (2023)

引用0浏览0引用

Abstract CT196: Early Results of a Safety and Efficacy Study of Allogeneic TruUCAR™ GC502 in Patients with Relapsed/refractory B-cell Acute Lymphoblastic Leukemia (r/r B-ALL)

Shiqi Li,Xinxin Wang,Zhongtao Yuan,Lin Liu,Yu Li,Jia Liu,Jiaping He,Zhimin Li, Wei Zhao,Jianning Ge,Yajin Ni,Lianjun Shen, Wei Cao,Xi Zhang,Martina Sersch,Sanbin Wang

Cancer Researchno. 12_Supplement (2022)

引用0浏览0引用

P370: EARLY RESULTS OF A SAFETY AND EFFICACY STUDY OF ALLOGENEIC TRUUCAR™ GC502 IN PATIENTS WITH RELAPSED/REFRACTORY B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA (R/R B-ALL)

Shiqi Li,Xinxin Wang,Zhongtao Yuan,Lin Liu,Yu Li,Jia Liu,Jiaping He,Zhimin Li,Wei Zhao,Jianning Ge,Yajin Ni,Lianjun Shen, Wei Cao,Xi Zhang,Martina Sersch,Sanbin Wang

HemaSphere（2022）

引用0浏览0引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn